Science Explorer Back to mapMap

Most cited papers from Clinvest (United States)

What are the most cited papers from Clinvest (United States)?

The most cited paper from Clinvest (United States) is "Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial" (Hong Qiang Sun, David W. Dodick, Stephen David Silberstein et al., 2016), with 367 citations. Next come "Chronic migraine headache prevention with noninvasive vagus nerve stimulation" (258) and "Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot study" (215).

Showing 50 of 54 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial Hong Qiang Sun, David W. Dodick, Stephen David Silberstein et al. · The Lancet Neurology 14 Feb 2016 367
2 Chronic migraine headache prevention with noninvasive vagus nerve stimulation Stephen David Silberstein et al. · Neurology Open access 14 Jul 2016 258
3 Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot study Peter James Goadsby, BM Grosberg, Alexander Mauskop et al. · Cephalalgia 7 Mar 2014 215
4 ANAM® Genogram: Historical perspectives, description, and current endeavors☆ D REEVES, Kathryn P. Winter, Joseph Bleiberg et al. · Archives of Clinical Neuropsychology Feb 2007 188
5 Effect of repeated exposures to cold on cognitive performance in humans Taija Mäkinen, Lawrence A. Palinkas, Dennis Reeves et al. · Physiology & Behavior 24 Nov 2005 161
6 Automated Neuropsychological Assessment Metrics sports medicine battery Alison N. Cernich, D REEVES, WEI MING SUN et al. · Archives of Clinical Neuropsychology 22 Nov 2006 130
7 A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With T x360 ® as Acute Treatment for Chronic Migraine Roger K. Cady, Joel R. Saper, Kent Dexter et al. · Headache The Journal of Head and Face Pain Open access 23 Oct 2014 117
8 A Double‐Blind Placebo‐Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesic TM M) in the Treatment of Migraine Roger K. Cady, Jerome Goldstein, Robert Nett et al. · Headache The Journal of Head and Face Pain Jun 2011 74
9 Combat-Related Post-Traumatic Stress Disorder: A Case Report Using Virtual Reality Exposure Therapy with Physiological Monitoring Dennis Patrick Wood, Jennifer L. Murphy, Robert N. McLay et al. · CyberPsychology & Behavior Apr 2007 70
10 Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx 360 ® Device for Treatment of Chronic Migraine Roger K. Cady, Roger K. Cady, Joel R. Saper et al. · Headache The Journal of Head and Face Pain Open access 31 Mar 2015 63
11 Reference Values for Performance on the Automated Neuropsychological Assessment Metrics V3.0 in an Active Duty Military Sample Dennis Reeves, Joseph Bleiberg, Tresa Roebuck‐Spencer et al. · Military Medicine Open access Oct 2006 58
12 Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease Daniel M. Levinson, Dennis Reeves, Jocelyn Dawn Watson et al. · Archives of Clinical Neuropsychology Open access 28 Oct 2004 57
13 Neuropsychological assessment in extreme environments Mark J. Lowe, Wayne C. Harris, Robert R. Kane et al. · Archives of Clinical Neuropsychology Open access 5 Dec 2006 49
14 Reference Data from the Automated Neuropsychological Assessment Metrics for Use in Traumatic Brain Injury in an Active Duty Military Sample Andrea S. Vincent, Joseph Bleiberg, Sam Yan et al. · Military Medicine Sep 2008 48
15 Nurse‐Based Education: An Office‐Based Comparative Model for Education of Migraine Patients Roger K. Cady, Kathleen U. Farmer, M.E. Beach et al. · Headache The Journal of Head and Face Pain 28 Mar 2008 42
16 Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase. Roger K. Cady, Curtis P. Schreiber, M.E. Beach et al. · PubMed Sep 2005 41
17 Environmental influences on hypothalamic–pituitary–thyroid function and behavior in Antarctica Lawrence A. Palinkas, Kathleen R. Reedy, Marc A. Shepanek et al. · Physiology & Behavior 19 Jun 2007 39
18 Simple and Efficient Recognition of Migraine With 3‐Question Headache Screen Roger K. Cady, Leona D. Borchert, William M. Spalding et al. · Headache The Journal of Head and Face Pain Apr 2004 36
19 Predictors of Adherence to Triptans: Factors of Sustained vs Lapsed Users Roger K. Cady, Morris Maizels, Dennis Reeves et al. · Headache The Journal of Head and Face Pain 11 Feb 2009 35
20 Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine Roger K. Cady, Roger K. Cady, Sagar Munjal et al. · The Journal of Headache and Pain Open access 7 Feb 2017 34
21 Evaluation of Sumatriptan‐Naproxen in the Treatment of Acute Migraine: A Placebo‐Controlled, Double‐Blind, Cross‐Over Study Assessing Cognitive Function Keith R. Edwards, Barbara Rosenthal, Kathleen U. Farmer et al. · Headache The Journal of Head and Face Pain 26 Dec 2012 32
22 A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine Sagar Munjal, Elimor Brand‐Schieber, Kent S. Allenby et al. · The Journal of Headache and Pain Open access Mar 2017 25
23 Influence of Demographics on Computerized Cognitive Testing in a Military Sample Tresa Roebuck‐Spencer, Dennis Reeves, Joseph Bleiberg et al. · Military Psychology 25 Jun 2008 25
24 The ARES® test system for palm OS handheld computers Timothy F. Elsmore, D REEVES, Andrea N. Reeves · Archives of Clinical Neuropsychology Open access 13 Dec 2006 19
25 Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study David True, Kathleen Mullin, Robert S. Croop · Pain and Therapy Open access 10 Jul 2024 18
26 A randomized placebo‐controlled clinical trial of the effectiveness of thyroxine and triiodothyronine and short‐term exposure to bright light in prevention of decrements in cognitive performance and mood during prolonged Antarctic residence Lawrence A. Palinkas, Kathleen R. Reedy, Marc A. Shepanek et al. · Clinical Endocrinology 24 Jul 2009 18
27 Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg Curtis P. Schreiber, Roger K. Cady · Clinical Therapeutics 2007 18
28 Treatment of Chronic Migraine: A 3‐Month Comparator Study of Naproxen Sodium vs SumaRT / N ap Roger K. Cady, Robert Nett, Kent Dexter et al. · Headache The Journal of Head and Face Pain 10 Sep 2013 17
29 Two Center, Randomized Pilot Study of Migraine Prophylaxis Comparing Paradigms Using Pre‐Emptive Frovatriptan or Daily Topiramate: Research and Clinical Implications Roger K. Cady, James Voirin, Kathleen U. Farmer et al. · Headache The Journal of Head and Face Pain 21 Dec 2011 16
30 Uncovering Latent Deficits Due to Mild Traumatic Brain Injury by Using Normobaric Hypoxia Stress Leonard A. Temme, Joseph Bleiberg, Dennis Reeves et al. · Frontiers in Neurology Open access 2013 16
31 Psychoneuroendocrine effects of combined thyroxine and triiodothyronine versus tyrosine during prolonged Antarctic residence Lawrence A. Palinkas, Kathleen R. Reedy, Mark W. Smith et al. · International Journal of Circumpolar Health Open access Dec 2007 16
32 An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations Eric Weidmann, Jeffrey R. Unger, Stephen D. Blair et al. · Clinical Therapeutics 2003 14
33 The Development of a Survey to Measure Completeness of Response to Migraine Therapy Cheryl D. Coon, Sheri E. Fehnel, Kimberly H. Davis et al. · Headache The Journal of Head and Face Pain Apr 2012 10
34 Managing Organizational Conflicts: A Study among Organizations in Kosovo Saxhide Mustafa, Fatos Berani, Hajdin Berisha · Journal of Educational and Social Research Open access 2019 6
35 Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats Melissa Petersen, Riaan Maree, Henda Pretorius et al. · Parasites & Vectors Open access 26 Jan 2023 5
36 Development of the functional assessment of migraine scale using a patient guided approach Erin Michelle Buchanan, Heather R. Manley, James Scott Sly et al. · Quality of Life Research 25 Oct 2022 5
37 Efficacy of fluralaner chewable tablets (Bravecto®) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs Melissa Petersen, Riaan Maree, Alta Viljoen et al. · Parasites & Vectors Open access 8 Feb 2023 4
38 Sublingual Feverfew/Ginger ( LipiGesic M ) Reanalysis of Data Roger K. Cady, Daniel Serrano, Richard B. Lipton et al. · Headache The Journal of Head and Face Pain Feb 2013 2
39 Rethinking organizational strategies and policies for employee retention in the wake of the migration crisis Hajdin Berisha, Mirsim Gashi · Corporate and Business Strategy Review Open access 2023 1
40 Quantitative determination of the content of venlafaxine and its active metabolite in human plasma using liquid chromatography-mass spectrometry Ю.И. Кузьмин, Ангелина Игоревна Платова, A.S. Konstantinova et al. · Pharmacokinetics and Pharmacodynamics Open access 18 Jan 2023 1
41 An extension of the QWERTY effect: Not just the right hand, expertise and typeability predict valence ratings of words Erin Michelle Buchanan, K. D. Valentine, Addie Wilkowsky · Psychology of Language and Communication Open access 2022 1
42 Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects А. Л. Хохлов, D. Yu. Grebenkin, E. K. Faeva et al. · Pharmacokinetics and Pharmacodynamics Open access May 2022 1
43 Development of an Operational Setting Specific Field Cognitive Assessment Procedure Wayne C. Harris, Dennis Reeves, Timothy F. Elsmore et al. · Proceedings of the Human Factors and Ergonomics Society Annual Meeting Open access Oct 2006 1
44 EHMTI-0268. Long term efficacy of repetitive sphenopalatine blockade with bupivacaine vs. Saline with the tx360 device for treatment of chronic migraine RK Cady, HR Manley, RJ Cady et al. · The Journal of Headache and Pain Open access 18 Sep 2014 1
45 Frontier sites in clinical trials: Opportunities, challenges, and models Andrea Bastek, Amanda Zenere, Heather Manley et al. · Contemporary Clinical Trials Communications Open access 25 Nov 2025 0
46 PCSK9 and ANGPTL3 inhibitors in homozygous familial hypercholesterolemia: A meta-analysis of randomized clinical trials Ibadete Bytyçi, Michael Y. Henein, Sefer Bytyqi et al. PreprintOpen access 7 Feb 2025 0
47 Bеnefits of the «resource match» method in the construction of graphic maps of commercial enterprise Dmitriy Victorovich Shvetsov · Theoretical economics 2022 0
48 Pharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of Samples А. Л. Хохлов, D. Yu. Grebenkin, E. K. Faeva et al. · Drug development & registration Open access 28 Feb 2023 0
49 Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration А. Л. Хохлов, A. A. Khokhlov, A. E. Miroshnikov et al. · Pharmacokinetics and Pharmacodynamics Open access 19 Jan 2023 0
50 Randomized, Double-Blind, Pilot Study Comparing 3 Mg Subcutaneous Sumatriptan With 6 Mg Subcutaneous Sumatriptan Using DFN-11 Autoinjector for the Acute Treatment Of Rapidly-Escalating Migraine Attacks (P1.10-007) Roger K. Cady, Sagar Munjal, Ryan J. Cady et al. · Neurology 9 Apr 2019 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.